Authors:
Bosi, E
Minelli, R
Bazzigaluppi, E
Salvi, M
Citation: E. Bosi et al., Fulminant autoimmune Type 1 diabetes during interferon-alpha therapy: a case of Th1-mediated disease?, DIABET MED, 18(4), 2001, pp. 329-332
Citation: M. Salvi et A. Toninello, Aroclor 1254 inhibits the mitochondrial permeability transition and release of cytochrome c: A possible mechanism for its in vivo toxicity, TOX APPL PH, 176(2), 2001, pp. 92-100
Authors:
Salvi, M
Pedrazzoni, M
Girasole, G
Giuliani, N
Minelli, R
Wall, JR
Roti, E
Citation: M. Salvi et al., Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking, EUR J ENDOC, 143(2), 2000, pp. 197-202
Citation: A. Toninello et al., The membrane permeability transition in liver mitochondria of the great green goby Zosterisessor ophiocephalus (pallas), J EXP BIOL, 203(22), 2000, pp. 3425-3434
Authors:
Minelli, R
Braverman, LE
Valli, MA
Schianchi, C
Pedrazzoni, M
Fiaccadori, F
Salvi, M
Magotti, MG
Roti, E
Citation: R. Minelli et al., Recombinant interferon alpha (rIFM-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis, CLIN ENDOCR, 50(1), 1999, pp. 95-100
Authors:
Gunji, K
De Bellis, A
Kubota, S
Swanson, J
Wengrowicz, S
Cochran, B
Ackrell, BAC
Salvi, M
Bellastella, A
Bizzarro, A
Sinisi, AA
Wall, JR
Citation: K. Gunji et al., Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism, J CLIN END, 84(4), 1999, pp. 1255-1262
Authors:
Salvi, M
Spaggiari, E
Neri, F
Minelli, R
Roti, E
Citation: M. Salvi et al., Expulsion of an artificial eye in a patient with thyroid-associated ophthalmopathy and surgical anophthalmos, AM J MED, 107(2), 1999, pp. 191-192